CSafe Global Announces Appointment of New Board Member
PR94664
DAYTON, Ohio, Feb. 24, 2022 /PRNewswire=KYODO JBN/ --
- Joe Newell joins board of directors as part of the company's ongoing
commitment to improving the cell and gene therapy supply chain
CSafe Global [
], the innovation leader in temperature-controlled container solutions for the
transport of life-enhancing pharmaceuticals, announced today that Joe Newell
has been appointed to the company's board of directors. With this appointment
the Board will comprise 9 directors.
Photo - https://mma.prnewswire.com/media/1752734/CSafe_Global_Joe_Newell.jpg
Logo - https://mma.prnewswire.com/media/1501954/CSafe_Global_Logo.jpg
"We are pleased to welcome Joe to the CSafe board," said CSafe CEO and board
member, Patrick Schafer. "His vast experience from across the biopharma
industry, including his deep understanding of the cell and gene therapies
space, will be invaluable to CSafe as we grow our business in that sector and
further our mission to safely deliver life-enhancing products to patients."
"Joe is a pivotal addition to our board," said Bill Mitchell, CSafe Chairman of
the Board and Executive in Residence for Frazier Healthcare Partners.
"Expanding our portfolio to meet the unique needs of the cell and gene therapy
market has been a core strategic focus for CSafe. Joe's expert guidance in this
space will help accelerate our expansion of a truly client-centric solution."
Mr. Newell has spent his near 30-year career in the pharmaceutical and life
sciences industries. He most recently served as Chief Operations Officer for
Atara Biotherapeutics, a pioneer in allogeneic T-cell immunotherapies for
patients with serious diseases including hematologic cancers, autoimmune
disease and solid tumors. At Atara he oversaw Process Sciences, Manufacturing,
Quality, Program Management, Alliance Management, and Enterprise Services.
Prior to joining Atara, Mr. Newell held leadership roles in manufacturing,
operations, supply chain and logistics for multiple industry-leading drug
development and pharma services organizations, including Alexion
Pharmaceuticals, Amgen, Catalent Pharma Services and Cardinal Health. He holds
a bachelor's degree in Biology from California State Polytechnic University –
Pomona.
"I am extremely excited to join the CSafe Global board and work with a seasoned
and highly successful executive team," said Newell. "Csafe is a mission driven
company that leads with core values that I appreciate and a true passion for
quality and service. The company is well-positioned to deliver an unmatched,
holistic cell and gene therapy cold chain portfolio solution and distribution
network to help ensure these critical life-saving therapies can reach the
patients who need them."
Media Contact:
Lori Conaway
Global Marketing Communications
+1 405.633.2344
lconaway@csafeglobal.com
About CSafe Global
CSafe Global provides end-to-end thermal shipping solutions to the
pharmaceutical and life science industries worldwide. An industry innovator,
CSafe provides AI-enabled lease forecasting to ensure active container
availability and real-time shipment visibility for customers to monitor
shipments and intervene to preserve a payload when needed. CSafe offers
industry-leading maintenance and reuse programs for active and passive
containers providing superior product performance and alignment with customer
sustainability objectives. With a presence in 150 countries, 24/7 support and
100% container availability, CSafe is well-positioned to be the partner of
choice in the cold chain. csafeglobal.com [
]
SOURCE CSafe Global
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。